Medical devices utilizing animal tissues and their derivatives - Principles for elimination and/or inactivation of transmissible spongiform encephalopathy (TSE) agents and validation assays for those processes1 Scope This Technical Report offers suggestions for designing and conducting validation assays to help determine if processes used in the manufacture of medical devices derived from non viable animal tissues might serve to reduce the risk of iatrogenic transmission of transmissible spongiform encephalopathies (TSEs). The TSE removal methods used to process animal tissues should also reduce the risk of transmitting TSE infections via non viable

It establishes

BS EN 924 specifies a method for determining the flashpoint of adhesives containing volatile organic compounds and makes allowance for deviations from standard atmospheric pressure

clinical mammography units are not suited for producing the radiation qualities in Clauses 11 to 14 without modification

and incorporated a number of best practices from modeling language design

The clean-up procedure specified in this International Standard is not intended to replace proper system flushing procedures

from two or more independent a

Conduct of the study

BS 7383 provides specifications such as:

during a vibration test on a seismic detector)

having a cross-sectional area up to and including 6 mm2

The standard also gives guidance on where the reliability stress screening should be carried out

This standard includes various procedures for dose setting using bioburden information (Method 1)